'Mild' hypocalcaemia: asymptomatic; serum calcium >1.9 mmol/L.
Introduction
Acute hypocalcaemia can be life threatening, necessitating urgent treatment. In severe cases, intravenous calcium forms the mainstay of initial therapy, but it is essential to ascertain the underlying cause and commence specific therapy as early as possible. This guideline aims to take the non-specialist through the initial phase of assessment and management.
Clinical presentation Potential causes
Symptoms of hypocalcaemia typically develop when adjusted serum calcium levels fall below ~1.9 mmol/L. However, this threshold varies greatly and is dependent on the rate of fall.
Symptoms and signs of hypocalcaemia include:
• Peri-oral and digital paraesthesiae • Positive Trousseau's and Chvostek's signs • Tetany and carpopedal spasm • Laryngospasm • ECG changes (prolonged QT interval) and arrhythmia
• Seizure
The most common cause of acute symptomatic hypocalcaemia in hospital practice is disruption of parathyroid gland function due to total thyroidectomy. Hypocalcaemia may be temporary or permanent.
Other causes include:
• , 24 mmol/24 h, made up as 6 g of MgSO 4 (30 mL of 20%, 800 mmol/L, MgSO 4 ) in 500 mL Normal saline or 5% dextrose. Monitor serum Mg 2+ and aim to achieve normal serum magnesium level • If other cause of hypocalcaemia, treat underlying condition.
Severe hypocalcaemia
Severe hypocalcaemia: serum calcium <1.9 mmol/L and/or symptomatic at any level below reference range.
• This is a medical emergency • Administer i.v. calcium gluconate • Initially, give 10-20 mL 10% calcium gluconate in 50-100 mL of 5% dextrose i.v. over 10 min with ECG monitoring. This can be repeated until the patient is asymptomatic. It should be followed up with a calcium gluconate infusion as follows:
-Dilute 100 mL of 10% calcium gluconate (10 vials) in 1 L of Normal saline or 5% dextrose and infuse at 50-100 mL/h. (Calcium chloride can be used as an alternative to calcium gluconate, but it is more irritant to veins and should only be given via a central line) -Titrate the rate of infusion to achieve normocalcaemia and continue until treatment of the underlying cause has taken effect 
Long-term follow-up
For patients commenced on alfacalcidol or calcitriol, monitoring of adjusted serum calcium levels should initially be performed approximately one week post discharge, then if satisfactory at one, three and then six months. Follow-up by a specialist with an interest in calcium disorders is recommended.
Disclaimer
The document should be considered as a guideline only; it is not intended to determine an absolute standard of medical care. The doctors concerned must make the management plan for an individual patient.
